[Clinical evaluation of Uro-Vaxom in treatment of recurrent urinary tract infections in girls].
Uro-Vaxom was used in the treatment of recurrent urinary tract infections in 28 girls. Most of them (27/28) tolerated the drug very well, no side effects were observed. We stopped administration of the Uro-Vaxom in one girl during the first month of treatment because of vomiting. Uro-Vaxom efficiency was, therefore, evaluated in 27 girls. Uro-Vaxom was found to be a valuable drug, supplementing antibiotic therapy in recurrent urinary tract infections caused by E. coli.
Gołabek
B
B
Klinika Pediatrii Instytutu Matki i Dziecka w Warszawie.
Nowakowska
K
K
Słowik
M
M
Paruszkiewicz
G
G
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000667:Ampicillin / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004926:Escherichia coli; D005260:Female; D005661:Furagin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D012008:Recurrence; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000892:Anti-Infective Agents, Urinary; D005839:Gentamicins; D000667:Ampicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D005661:Furagin
Kliniczna ocena preparatu Uro-Vaxom w leczeniu nawracajacych zakazeń układu moczowego u dziewczynek.